Document is current
Any future updates will be listed below
-
Authors
Miyoshi, Jun
Maeda, Tsubasa
Matsuoka, Katsuyoshi
Saito, Daisuke
Miyoshi, Sawako
Matsuura, Minoru
Okamoto, Susumu
Tamura, Satoshi
Hisamatsu, Tadakazu
-
Funding
Funding for this research was provided by:
The Japan Sciences Research Grant for Research on Intractable Diseases
- License Information
-
More Information
Article History
Received: 8 June 2021
Accepted: 4 August 2021
First Online: 12 August 2021
Competing interests
: Jun Miyoshi has received lecture fees from JIMRO Co. and Takeda Pharmaceutical Co. Ltd. Katsuyoshi Matsuoka has served as a scientific adviser for EA Pharma; served on advisory boards for Bristol-Meyers Squibb, and Eli Lilly and Company; received speaker fees from Mitsubishi Tanabe Pharma, Takeda Pharmaceutical, Janssen, AbbVie, EA Pharma, Pfizer Inc, Mochida Pharmaceutical, Kyorin Pharmaceutical, Zeria Pharmaceutical, Kissei Pharmacetucal, and JIMRO; and received research grants from Mitsubishi Tanabe Pharma, Mochida Pharmaceutical, Kyorin Pharmaceutical, AbbVie, Takeda Pharmaceutical, Nippon Kayaku, EA Pharma, Kissei Pharmaceutical, and JIMRO Co. Minoru Matsuura has received consulting and lecture fees from Janssen Pharmaceutical K.K., Takeda Pharmaceutical Co. Ltd., AbbVie GK, Mitsubishi Tanabe Pharma Corporation, Kyorin Pharmaceutical Co. Ltd., Mochida Pharmaceutical Co., Ltd., JIMRO Co., Nippon Kayaku Co. Ltd., Mylan EPD G.K., and Aspen Japan Co. Ltd. Tadakazu Hisamatsu has performed Joint Research with Alfresa Pharma Co. Ltd., EA Pharma Co. Ltd.; received grant support from Mitsubishi Tanabe Pharma Corporation, EA Pharma Co. Ltd., AbbVie GK, JIMRO Co. Ltd., Zeria Pharmaceutical Co. Ltd., Daiichi-Sankyo, Kyorin Pharmaceutical Co. Ltd., Nippon Kayaku Co. Ltd., Takeda Pharmaceutical Co. Ltd., Pfizer Inc., Mochida Pharmaceutical Co., Ltd.; and received consulting and lecture fees from EA Pharma Co. Ltd., AbbVie GK, Celgene K.K., Janssen Pharmaceutical K.K., Pfizer Inc., Nichi-Iko Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharma Corporation , Kyorin Pharmaceutical Co. Ltd., JIMRO Co., Mochida Pharmaceutical Co., Ltd., and Takeda Pharmaceutical Co. Ltd. Tsubasa Maeda, Daisuke Saito, Sawako Miyoshi, Susumu Okamoto, and Satoshi Tamura have no conflict of interest.
